Get in touch
Navigation
  • Home
  • Team
  • Companies
  • News & Ideas
  • Careers
  • Investor Portal
  • Contact Us
Address
Bold Capital Partners
225 Santa Monica Blvd.
Suite 900
Santa Monica
CA 90401
Google Maps
Contacts
Email us
Socials
LinkedIn
Recent Investments
Form Bio
Form Bio Form Bio
Syntis Bio
Syntis Bio Syntis Bio
Gameto
Gameto Gameto

Insilico Medicine

 - 
Insilico Medicine -  Insilico Medicine - 
Insilico Medicine Insilico Medicine
Insilico is utilizing and developing the latest innovations in artificial intelligence to bridge the gap between biomarker development and drug discovery. Insilico’s comprehensive drug discovery engine drastically reduces the time and cost of identifying promising drug candidates.
Visit Company Website
Alex Zhavoronkov
Alex Zhavoronkov CEO
Technologies
  • Applied AI,
  • Biotechnology,
  • Computational Biology
  • Follow
  • LinkedIn
  • Twitter
  • Company News
    View All News
                     Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19
    02.23.23
    Healthcare
    Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19
                     Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
    02.08.23
    Healthcare
    Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
                     Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle
    01.10.23
    Healthcare
    Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle
                     Insilico Medicine CEO Alex Zhavoronkov Featured Among World’s Top 50 Innovators
    09.25.22
    Healthcare
    Insilico Medicine CEO Alex Zhavoronkov Featured Among World’s Top 50 Innovators
                     Insilico Medicine Boosts Latest Funding Round to $95 Million with Aramco Backing
    08.12.22
    Healthcare
    Insilico Medicine Boosts Latest Funding Round to $95 Million with Aramco Backing
                     Insilico Medine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-Powered Drug Discovery Robotics Laboratory
    06.06.22
    Healthcare
    Insilico Medine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-Powered Drug Discovery Robotics Laboratory

    Jobs

    Interested in a job at Insilico Medicine?
    View Jobs
    Deciduous Therapeutics
    Deciduous Therapeutics
    Next